Clinical trial
Glivec (Imatinib Mesylate) in the Treatment of Polycythemia Vera
NCT00430066 is registered in ClinicalTrials.gov with Niguarda Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glivec (Imatinib Mesylate) in the Treatment of Polycythemia Vera
- Lead sponsor
- Niguarda Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- September 30, 2012
- Enrollment
- 9 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.